Package 0069-0504-30

Brand: bosulif

Generic: bosutinib
NDC Package

Package Facts

Identity

Package NDC 0069-0504-30
Digits Only 0069050430
Product NDC 0069-0504
Product ID 0069-0504_ca8600d9-46e6-402d-89f9-bc6a156bf751
Description

30 CAPSULE in 1 BOTTLE (0069-0504-30)

Marketing

Marketing Status
Marketed Since 2024-01-02
Brand bosulif
Generic bosutinib
Sample Package No

Linked Drug Pages (1)

BOSULIF ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ca8600d9-46e6-402d-89f9-bc6a156bf751", "openfda": {"upc": ["0300691014158", "0300690504308", "0300690193014", "0300690136011", "0300690135014"], "unii": ["844ZJE6I55"], "spl_set_id": ["adc84ad5-a04d-4fee-9ba8-91f7abd928e3"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (0069-0504-30)", "package_ndc": "0069-0504-30", "marketing_start_date": "20240102"}], "brand_name": "BOSULIF", "product_id": "0069-0504_ca8600d9-46e6-402d-89f9-bc6a156bf751", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "0069-0504", "generic_name": "Bosutinib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BOSULIF", "active_ingredients": [{"name": "BOSUTINIB MONOHYDRATE", "strength": "50 mg/1"}], "application_number": "NDA217729", "marketing_category": "NDA", "marketing_start_date": "20240102", "listing_expiration_date": "20271231"}